Skip to main content
The drug industry's voice for manufacturing excellence
Production
Development
Information Technology
Compliance
Quality & Risk
Sections
Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sectors
Special
Webinars
Podcasts
E-Handbooks
Industry News
Magazine Archives
Contact
Newsletter Subscription
Contact Us
Advertise
Follow us on
https://www.facebook.com/pages/Pharmaceutical-Manufacturing/140261116014887
http://www.linkedin.com/groups?gid=1813799
http://twitter.com/PharmaMfg
Home
Mergers & Acquisitions: Do They Add Value?
From
Knowledge@Wharton
, a podcast/transcription of an
interview with Wharton professor Harbir Singh.
pharmamanufacturing
Jan. 25, 2007
Add Us On Google
From
Knowledge@Wharton
, a podcast/transcription of an
interview with Wharton professor Harbir Singh.
About the Author
pharmamanufacturing
pharmamanufacturing
Sign up for our eNewsletters
Get the latest news and updates
Sign Up
Related
Charles River reports lower Q4 2025 revenue in struggling CDMO business
Fujifilm doubles quality control footprint at Danish commercial-scale manufacturing site
Sponsored
2026 Manufacturing Pharma Trends for Life Sciences
Sponsored
2026 AI Trends in Life Sciences
Trending
J&J’s supply chain restructuring to cost up to $750M, reduce manufacturing footprint
Samsung Biologics makes $1.8B all-cash offer to buy PolyPeptide Group AG
FDA picks seven companies for PreCheck pilot program including two CDMOs
Sponsored Picks
Sponsored
2026 Manufacturing Pharma Trends for Life Sciences
Sponsored
2026 AI Trends in Life Sciences
Sponsored
2026 Manufacturing Medical Device Trends for Life Sciences
Load More Content